Factors Influencing decrease in thinking/reasoning/remebering function after living donor liver transplant surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: K730- Chronic persistent hepatitis, notelsewhere classified
- Registration Number
- CTRI/2021/01/030658
- Lead Sponsor
- Deepak Mishra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients undergoing elective LDLT
Exclusion Criteria
No previous neurological illness, ALF, On ventilator more than 7 days post operatively
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive function scoresTimepoint: Cognitive function scores <br/ ><br>Baseline, Post op day 7, Post op day 14
- Secondary Outcome Measures
Name Time Method il( No secondary outcomes assessed)Timepoint: Nil
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms contribute to cognitive decline after LDLT in patients with chronic hepatitis C (K730)?
Are there specific biomarkers that predict post-LDLT cognitive dysfunction in liver transplant recipients?
How does LDLT compare to other liver transplant methods in terms of cognitive function outcomes for chronic hepatitis patients?
What are the potential adverse events affecting cognitive function following LDLT, and how can they be managed?
What combination therapies or compounds are being explored to mitigate cognitive decline after liver transplantation?